PRODUCT MONOGRAPH. PR. Cathflo. ® alteplase, recombinant . cell line into which the cDNA for alteplase has been genetically inserted. Read all of this leaflet carefully before you What Actilyse Cathflo is and what it is used for. 2. Contents of the pack and other information. 1. Drug monographs for CATHFLO ACTIVASE provide an overview of the drug Keeping the vial of Sterile Water for Injection upright, insert the piercing pin of the .
|Published (Last):||2 December 2016|
|PDF File Size:||4.13 Mb|
|ePub File Size:||19.84 Mb|
|Price:||Free* [*Free Regsitration Required]|
Severe Based on the pharmacology of warfarin, other thrombolytic agents could cause additive risk of bleeding when given concurrently pacmage warfarin. I found one instance where they infused 2mg over a 24 period? Complete dissolution should occur within 3 minutes. Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies in animals have not been performed to evaluate the carcinogenic potential or the effect on fertility.
The information contained in this section of the site is intended for U. Bismuth Subsalicylate; Metronidazole; Tetracycline: Leave it for the full !
All ONS Member Community
Pregnancy There are no adequate and well-controlled studies in pregnant women. Be sure to direct the stream of water into the lyophilized cake. Three 3 hour intravenous infusion. Copyright Oncology Nursing Society. Because omega-3 fatty acids inhibit platelet aggregation, caution is advised when icosapent ethyl is used concurrently with anticoagulants, platelet inhibitors, or thrombolytic agents.
During the first hour, 60 mg is administered over one hour, as a 6—10 mg IV bolus administered over 1—2 minutes then the remaining 50—54 mg, given by IV infusion over the remainder of the hour. Pregnancy There are no adequate and well-controlled studies in pregnant women. If the mg vial is used, the needle should be inserted away from the puncture mark made by the transfer device. packagee
Cathflo Activase (alteplase) dose, indications, adverse effects, interactions from
Children weighing 10 to 29 kg. We do not record any personal information entered above. We had great success with this. Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered with an SNRI. I must lackage the question as I am hearing lots of rumble from my in-patient colleagues about Your Name Your name is required.
Moderate Fish oil, omega-3 fatty acids inhibit platelet aggregation, caution is advised when fish oils are used concurrently with anticoagulants, platelet inhibitors, or thrombolytic agents.
Randomized controlled trials have demonstrated beneficial outcomes when fibrinolytic therapy is administered as early as possible after onset of STEMI symptoms e. Recombinant form of human tissue packge activator Used for acute ischemic stroke, acute PE, or acute coronary arterial thromboembolism associated with evolving transmural MI Also used for the restoration of function to central venous access devices.
If this method pavkage used with 50 mg vials, the syringe should not be primed with air and the needle should be inserted into the vial stopper.
Unlike streptokinase or urokinase, most of the activity of alteplase is dependent on the presence of fibrin. Moderate An additive risk of bleeding may be seen in patients receiving enoxaparin in combination with other agents known to increase the risk of bleeding such as thrombolytic agents e. Major Concomitant administration of platelet inhibitors and thrombolytic agents could theoretically result in an increased risk of bleeding due to additive pharmacodynamic effects, and combinations of these agents should be approached with caution.
For reestablishing patency of an occluded IV catheter. Certain causes of catheter dysfunction should be considered before treatment with Cathflo Activase e.
All ONS Member Community – Oncology Nursing Society
In clinical trials, alteplase was administered by catheter-directed intra-arterial administration. Separate the alteplase vial from the transfer device and gently swirl to dissolve the cahhflo. The most frequent adverse reaction associated with all thrombolytics in all approved indications is bleeding. Moderate Green tea has demonstrated antiplatelet and fibrinolytic actions in animals.
Moderate Platelet aggregation may be impaired by vilazodone due to platelet serotonin depletion, possibly increasing the risk of a bleeding complication e.
Visually inspect parenteral products for particulate matter and discoloration prior to administration whenever solution and container permit.
If there is still no blood return, a catheter dye study will be ordered. The solution may be used for intracatheter instillation within 8 hours following reconstitution when stored at 2 to 30 degrees C 36 to 86 degrees F.
Major Due to the increased bleeding risk, avoid concurrent use of rivaroxaban with thrombolytic agents; the safety of concomitant use has not been studied.
If wait time is an iss Efficacy results suggest a reduced but still favorable outcome in geriatric patients treated with alteplase for acute ischemic stroke.
Weight-based dosing of 0. Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered concurrently with venlafaxine. Excessive pressure should be avoided when Cathflo Activase is instilled into the catheter. If catheter function is restored, aspirate 4 to 5 mL of blood in patients weighing 10 kg or greater or 3 mL in patients packzge less than imsert kg to remove alteplase and residual clot.
Potential interactions between Cathflo Activase and laboratory tests have not been studied. Long-term coadminstration is not recommended.